Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Shafrin

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Journal of Medical Economics|July 19, 2021
Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlistSyvart Dennen, Oliver Díaz Espinosa, Kelly Birch, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 4, 2024
Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data AnalysisDenise Clayton, Jason Shafrin, Glorian Yen, et al.
Journal of Medical Economics|January 7, 2020
Modeling the impact of patient treatment preference on health outcomes in relapsing-remitting multiple sclerosisEmma van Eijndhoven, Michelle Brauer, Rebecca Kee, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Measuring the Value Healthy Individuals Place on Generous Insurance Coverage of Severe Diseases: A Stated Preference Survey of Adults Diagnosed With and Without Lung CancerJason Shafrin, Suepattra G May, Lauren M Zhao, et al.
Journal of Medical Internet Research|February 3, 2021
Adoption of Digital Health Technologies in the Practice of Behavioral Health: Qualitative Case Study of Glucose Monitoring TechnologySuepattra G May, Caroline Huber, Meaghan Roach, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Physician and Patient Preferences for Nonvalvular Atrial Fibrillation TherapiesJason Shafrin, Amanda Bruno, Joanna P MacEwan, et al.
Journal of Comparative Effectiveness Research|June 23, 2025
Cost impact of Bruton's tyrosine kinase inhibitor selection in Medicare patients with chronic lymphocytic leukemiaAdam S Kittai, Dipen A Patel, Jason Shafrin, et al.
The American Journal of Cardiology|July 4, 2015
Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United StatesMintu P Turakhia, Jason Shafrin, Katalin Bognar, et al.
Forum for Health Economics & Policy|July 15, 2025
Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in NeurologyJason Shafrin, Kyi-Sin Than, Jacob Fajnor, et al.
Journal of Managed Care & Specialty Pharmacy|August 24, 2022
Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitisAlexis Ogdie, Mark Hwang, Phani Veeranki, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Journal of Medical Economics|July 19, 2021
Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlistSyvart Dennen, Oliver Díaz Espinosa, Kelly Birch, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 4, 2024
Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data AnalysisDenise Clayton, Jason Shafrin, Glorian Yen, et al.
Journal of Medical Economics|January 7, 2020
Modeling the impact of patient treatment preference on health outcomes in relapsing-remitting multiple sclerosisEmma van Eijndhoven, Michelle Brauer, Rebecca Kee, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Measuring the Value Healthy Individuals Place on Generous Insurance Coverage of Severe Diseases: A Stated Preference Survey of Adults Diagnosed With and Without Lung CancerJason Shafrin, Suepattra G May, Lauren M Zhao, et al.
Journal of Medical Internet Research|February 3, 2021
Adoption of Digital Health Technologies in the Practice of Behavioral Health: Qualitative Case Study of Glucose Monitoring TechnologySuepattra G May, Caroline Huber, Meaghan Roach, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Physician and Patient Preferences for Nonvalvular Atrial Fibrillation TherapiesJason Shafrin, Amanda Bruno, Joanna P MacEwan, et al.
Journal of Comparative Effectiveness Research|June 23, 2025
Cost impact of Bruton's tyrosine kinase inhibitor selection in Medicare patients with chronic lymphocytic leukemiaAdam S Kittai, Dipen A Patel, Jason Shafrin, et al.
The American Journal of Cardiology|July 4, 2015
Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United StatesMintu P Turakhia, Jason Shafrin, Katalin Bognar, et al.
Forum for Health Economics & Policy|July 15, 2025
Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in NeurologyJason Shafrin, Kyi-Sin Than, Jacob Fajnor, et al.
Journal of Managed Care & Specialty Pharmacy|August 24, 2022
Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitisAlexis Ogdie, Mark Hwang, Phani Veeranki, et al.
Pageof 9